18 November 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE: BMY) on Wednesday reported preliminary results from two Phase 3 studies evaluating investigational drug KarXT (xanomeline and trospium chloride) for psychosis associated with Al...
18 November 2026 - Norwegian bladder cancer diagnostics company Photocure ASA (OSE: PHO) said on Wednesday that it has signed an agreement with pharmaceutical services provider Clinigen to supply Hexvix through a Named Patient Program (NPP) in more t...
18 November 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) announced on Wednesday that it has entered into an exclusive licensing agreement with biotechnology company Starna Therapeutics to develop and commercialise three preclinical in vi...
18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services prog...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an Investigational New Drug (IND) application to the ...